Login to Your Account



Spero pads syndicate, lands $51.7M series C for pipeline of antibacterials

By Marie Powers
News Editor

Wednesday, March 8, 2017

Spero Therapeutics LLC completed a $51.7 million series C preferred financing led by new investor GV (formerly Google Ventures) with the participation of additional new investors RA Capital Management and Rock Springs Capital.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription